A major genetic accelerator of cancer diagnosis: rs867228 in FPR1

Zsofia Sztupinszki; Julie Le Naour; Erika Vacchelli; Pierre Laurent-Puig; Suzette Delaloge; Zoltan Szallasi; Guido Kroemer

doi:10.1080/2162402X.2020.1859064

A major genetic accelerator of cancer diagnosis: rs867228 in FPR1

Oncoimmunology. 2021 Jan 6;10(1):1859064. doi: 10.1080/2162402X.2020.1859064.

Authors

Zsofia Sztupinszki^{1

2}, Julie Le Naour^{3

4

5}, Erika Vacchelli^{3

6}, Pierre Laurent-Puig^{3

7}, Suzette Delaloge^{5

8}, Zoltan Szallasi^{1

2}, Guido Kroemer^{3

6

9

10}

Affiliations

¹ Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.
² Danish Cancer Society Research Center, Copenhagen, Denmark.
³ Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Institut Universitaire de France, Paris, France.
⁴ Harvard Medical School, Boston, MA, USA.
⁵ Université Paris Sud, Paris Saclay, Faculty of Medicine Kremlin Bicêtre, France.
⁶ Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
⁷ Institut du Cancer Paris CARPEM, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
⁸ Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
⁹ Suzhou Institute for stems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.
¹⁰ Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Humans
Neoplasms* / diagnosis
Receptors, Formyl Peptide

Substances

FPR1 protein, human
Receptors, Formyl Peptide

Grants and funding

Z.S. is supported by the Research and Technology Innovation Fund (KTIA_NAP_13-2014-0021 and NAP2-2017-1.2.1-NKP-0002 to Z.S.); Breast Cancer Research Foundation (BCRF-18-159 to Z.S.) and the Novo Nordisk Foundation Interdisciplinary Synergy Programme Grant (NNF15OC0016584), Det Fri Forskningsrad (award number 19#7016-00345B); Department of Defense through the Prostate Cancer Research Program (award number is W81XWH-18-2-0056).